共 34 条
- [31] In Vivo T Cell Depletion with Antithymocyte Globulin or Alemtuzumab for Unrelated Donor Stem Cell Transplantation with Reduced Intensity Conditioning: Results of a Multicenter Randomized Phase II Clinical Trial (The Global Study) From the Gruppo Italiano Trapianto Di Midollo Osseo (GITMO) BLOOD, 2012, 120 (21)
- [32] Allogeneic stem cell transplantation from HLA-haploidentical relatives as treatment for children with hematologic malignancy; A phase I/II study using mobilized peripheral blood progenitor cells (PBPCs) that have undergone CD34 selection followed by CD2 depletion. BLOOD, 1997, 90 (10) : 958 - 958
- [33] Allogeneic stem cell transplantation from HLA-haploidentical donors as treatment for children with inborn errors; A phase I/II study using bone marrow or mobilized peripheral blood progenitor cells (PBPCs) that have undergone CD34 selection by micromagnetic beads method (Miltenyi device) BLOOD, 1998, 92 (10) : 291A - 291A
- [34] ALLOGENEIC STEM CELL TRANSPLANTATION FROM MATCHED RELATED DONOR IN PATIENTS OVER THE AGE OF 55 YEARS AFTER REDUCED INTENSITY CONDITIONING ASSOCIATING FLUDARABINE-IV BUSULFAN AND RABBIT-ANTITHYMOCYTE GLOBULIN: A PROSPECTIVE MULTICENTER PHASE II CLINICAL TRIAL WITH SOCIO ECONOMIC EVALUATION BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S344 - S344